A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate a Single-Dose Subcutaneous Axatilimab Compared With Intravenous Axatilimab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
- Status
- RECRUITING
- Phase
- N/A
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- Status
- RECRUITING
- Phase
- N/A
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Status
- RECRUITING
- Phase
- PHASE3
A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Bioequivalence of Ruxolitinib Extended Release (XR) Tablets With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
- Status
- RECRUITING
- Phase
- PHASE3
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Skin and Plasma Pharmacokinetic of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1